hotspot -WSS

hotspot

author：fashion 2025-10-08 16:20:22 - browse：32223

Susan Tousi is leaving Illumina to become CEO of cancer liquid-biopsy startup Delfi. Nasdaq

Delfi Diagnostics, a startup devising new ways to use routine blood draws to detect early signs of cancer, told STAT Thursday that it has appointed Susan Tousi, chief commercial officer for genomics giant Illumina, as its new CEO. She is the fourth senior executive to leave Illumina since June.

Tousi will start next week, just in time for the J.P. Morgan Healthcare Conference, while founding CEO Victor Velculescu will remain on the company’s board to help guide its research programs. Tousi’s selection is part of a bid by Delfi to expand its commercial efforts and build on the initial launch of its lung cancer screening test last fall, the latest example of growing interest in the vast and increasingly competitive liquid biopsy market.

Illumina’s own ambitions to enter this space recently came undone after a prolonged battle with U.S. and European regulators finally pushed the company to announce last month that it would divest Grail, which it had acquired for $8 billion two years earlier. Bas Verhoef, Illumina’s head of region for Europe, will serve as interim chief commercial officer.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Mifepristone protocols being wielded by pill's opponents in Supreme Court case

hotspot

WSS

NIH 'gain

9/11 first responders see higher rates of early onset dementia

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Change Healthcare cyberattack shows risk of industry consolidation

Alexander Morris lawsuit: Four Tops singer claims racist treatment at hospital

Vaccine side effects and injuries are worthy of scientific follow

knowledge

hotspot

Wikipedia

George Santos makes 1st court appearance after pleading not guilty to 13 counts

AI for biopsies can analyze microscopy images, help with diagnosis

New air purifier tech could be key to improving indoor air quality

Study fuels hope CAR

As demand for Covid shots wanes, Moderna seeks its next success

Prosthetic arms could feature tools instead of mechanical fingers

Jerome Adams on the need for new antivirals for Covid

Sanders eyes subpoena for Novo Nordisk exec on Ozempic, Wegovy

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Hospitals to project optimism at JP Morgan Healthcare Conference

leisure time

Are embryos people? Reproductive medicine's future depends on the answer

9/11 first responders see higher rates of early onset dementia

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Illegal vapes are widely sold. Congress wants the FDA to stop it

AI for biopsies can analyze microscopy images, help with diagnosis

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

hotspot

knowledge

hotspot

entertainment